Launch Templates & Operating Model
Standardize launch types through reusable areas, weighted requirements, blocking and evidence rules, due-date offsets, geographic applicability and RACI owner presets.
Know whether every product, SKU and country is ready—and permitted—to launch.
eGO connects internal process readiness with external market-entry limits. PATEX, MA and DA dates become visible, controlled inputs to every launch plan—continuously checked against target and forecast dates from the first launch wave to Go / No-Go, market entry and stabilisation.


Pharmaceutical launches depend on Regulatory, Supply, Quality, Packaging, Market Access, Medical, Commercial and local affiliate teams moving together. They also depend on external limits such as PATEX, MA and DA. When these two realities live in separate trackers, a launch can look operationally ready while its planned date is still impossible.
eGO creates one shared control picture: what is launching, where and when; what each team must complete; which external limit controls market entry; and whether target and forecast dates remain compliant. Conflicts are made visible across the portfolio and carried into accountable Go, Conditional Go, Hold or No-Go decisions.
One launch management environment for internal readiness, external market-entry control and evidence-based decisions.
Standardize launch types through reusable areas, weighted requirements, blocking and evidence rules, due-date offsets, geographic applicability and RACI owner presets.
Structure launch initiatives into coordinated waves and market launches, with clear dates, health, priority and ownership.
Define exactly which products, packs and local SKUs will launch in each country, including local names, GTINs and artwork references.
Capture PATEX, MA and DA limits by product and market, calculate the earliest permitted market entry and keep every launch plan aligned with the current external constraint landscape.
Apply the right template to each market launch, assign requirements and calculate readiness from weighted, evidence-based progress.
Connect regulatory, supply, quality, market access, medical and commercial activities so delays and critical-path impact become visible early.
Prepare a complete decision package and record Go, Conditional Go, Hold or No-Go decisions with conditions and accountable owners.
Bring blockers, risks, overdue requirements, escalations and corrective work into one controlled operational view.
Keep versioned documents, approvals and evidence linked to the requirement, gate and market launch they support.
Connect readiness and launch risk with forecast revenue, investment, probability of success and portfolio value at risk.
Give launch managers, local leads and functional owners a clear view of responsibility, workload, due dates and missing coverage.
Run advisory readiness, date-risk, completeness, change-impact and portfolio reviews without changing controlled process data.
eGO keeps every level connected—from launch initiative and wave to country, SKU, PATEX/MA/DA limits, readiness requirements and decision evidence.
Start with the approved project, its products, registered products and packagings. The Scope Matrix determines which exact packaging belongs to which country, creating a controlled foundation for launch creation and preventing invalid local SKU scope later in the process.
Capture PATEX, MA and DA limits as governed, country-specific records instead of copying dates between launch trackers. eGO keeps the protection type, territory, effective date, legal status, confidence, source, verification and review history together, with efficient entry across multiple markets.
Launch Templates are the backbone of consistent readiness. Configure applicability by launch type and geography, define functional areas and requirements, set criticality, weight, blocking and evidence rules, calculate due dates from the target launch date and preset RACI owners and deputies.
The New Launch wizard converts approved project scope into an executable launch structure. Select products and target markets, define the initiative and first wave, choose the launch type and target date, and apply the correct readiness template as the market launches are created.
The Launch Initiative detail keeps strategy, product scope, waves, countries and the resulting market launches together. Launch managers can understand sequencing across markets while each country remains an independently governed execution unit.
Market Launch Detail is the operational system of record. Its Overview brings product, country, local pack scope, ownership and launch dates together with the applicable external limits, earliest permitted market entry and a clear conflict status before teams move into readiness and governance execution.
For every market launch, eGO determines which protections apply, identifies the controlling constraint and calculates the legal earliest launch date with safety buffers and local waiting periods. Target and forecast dates are checked automatically; conflicts and stale reviews remain visible from the individual assessment to the portfolio-wide External Constraints cockpit.
The applied template becomes a versioned readiness snapshot for the market. Functional owners update requirements, resolve blockers and attach text, URL or approved-document evidence. Weighted scoring and critical rules then drive the launch health seen across the portfolio.
Milestones and dependencies make schedule impact explicit, while Actions & Risks turn exceptions into owned work. Target and forecast dates are continuously checked against approved PATEX, MA and DA limits; a conflicting date is blocked unless it follows a controlled launch-at-risk route. Material baseline changes remain traceable through change control.
Decision Package brings operational readiness together with the external market-access assessment: the legal earliest launch date, controlling constraint, unresolved impacts and any date conflict sit alongside evidence, exceptions, milestones and business context. Approvers can record Go, Conditional Go, Hold or No-Go with full rationale and history.
Documents move through versioning and approval workflows and approved versions can become readiness evidence. After launch, teams record the actual outcome, lessons learned and handover; closure locks operational editing while keeping the complete activity and decision history available.
Launch Portfolio and Control Center surface delayed markets, overdue requirements, external-limit conflicts, overdue reviews, upcoming gates and missing owners. The same market-entry status follows each launch through product, project and executive views, so management can focus on the launches where intervention and value are most at risk.

eGO owns launch readiness, external market-entry control and market launch decisions while connecting the work around them: portfolio priorities from ePM, regulatory status from eRA, approved artwork from eAW, controlled documents from eDOCS and quality or laboratory evidence from specialized systems.
eGO turns connected domain evidence into one coherent answer: are we ready and permitted to launch?
Artwork execution follows regulatory and launch change context.
Answer the operational and governance questions behind every successful market launch.
Optional Smart Actions review launch readiness, Go / No-Go inputs, date risk, completeness, exceptions, change impact and portfolio risk. Each analysis uses the selected launch context, returns structured findings for review and never changes controlled process data or replaces accountable decisions.
eGO reflects how pharmaceutical launches actually work: global initiatives become launch waves, waves become country launches, and every market has its own PATEX, MA and DA limits alongside SKU scope, owners, readiness evidence, dependencies, risks and decision history.
See how eGO can connect PATEX, MA and DA limits with country scope, functional readiness, evidence, dependencies and governance across your pharmaceutical launch portfolio.
Request a Demo